Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Mark"

5723 News Found

Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis
R&D | May 13, 2026

Roche wins CE mark for Alzheimer’s blood test that could transform early diagnosis

The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline


From lab bench to market: Strengthening translational research in India’s biotech ecosystem
Opinion | May 11, 2026

From lab bench to market: Strengthening translational research in India’s biotech ecosystem

India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells


Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO
Medical Device | May 08, 2026

Microsure secures CE mark for MUSA-3 system, appoints Alex Joseph as CEO

The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio


Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows


NIFTY Pharma remains resilient amid mixed market sentiment
News | May 05, 2026

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures


Aakash Healthcare publishes landmark study on integrated emergency clinical codes
Hospitals | May 01, 2026

Aakash Healthcare publishes landmark study on integrated emergency clinical codes

Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals


Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report
Biopharma | April 28, 2026

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation


India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
News | April 23, 2026

India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation

New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements


ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
Clinical Trials | April 22, 2026

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents